ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless ...

This summer, doctors at UnityPoint Health performed the QCA's first leadless pacemaker procedure. Now, Dr. Helbert Acosta ...

Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new research published today in Circulation ...

This week Cambridge Consultants unveiled a semi-leadless pacemaker it designed for start-up EBR Systems. The device, called Wireless Cardiac Stimulation system (WiCS), includes a leadless electrode ...

Please provide your email address to receive an email when new articles are posted on . A dual-chamber leadless pacemaker met 3-month safety and efficacy performance goals. The device avoids ...

Please provide your email address to receive an email when new articles are posted on . The first pacemaker implantation was performed in 1958, and the technology has undergone many advances since ...

Abbott's Aveir single chamber (VR) pacing system is the world's only leadless pacemaker with a unique mapping capability to assess correct positioning prior to placement Aveir VR has an increased ...

Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...

An experimental leadless pacemaker is able to capture enough energy from the heart to partially power the device, according to results from a new proof-of-concept study. The prototype device harvested ...

Commencement of LEADLESS II clinical research trial represents important milestone in bringing transformational pacing technology to U.S. patients ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, ...